Sign inJoin waitlistJoin the waitlist

MK

Marisa Kollmeier

Program Director, Brachytherapy Fellowship · New York Presbyterian Hospital

Credentials: · · ·

History

Brachytherapy Fellowship · New York Presbyterian Hospital
Present
Brachytherapy Service; Gynecologic Disease Site Director Division · New York Presbyterian Hospital
Present

Radiation Oncology
Icahn School of Medicine at Mount Sinai
2000–2003
Preliminary or Transitional Year
1999–2000
SACKLER SCH OF MED, TEL AVIV UNIV, RAMAT AVIV, ISRAEL
1995–1999

Research

Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
International journal of radiation oncology · 2012 · 416 citations
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy
European Urology · 2013 · 341 citations
Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer
International journal of radiation oncology · 2013 · 220 citations

Michael Zelefsky
78 papers
Sean McBride
38 papers
Yoshiya Yamada
27 papers
DG
Daniel Gorovets
25 papers
BC
Brett Cox
21 papers
KA
Kaled Alektiar
16 papers
NA
Nadeem Abu-Rustum
16 papers
Daniel Spratt
14 papers · 10 as a resident
RB
Richard Barakat
8 papers
Michael Folkert
7 papers · 4 as a resident
Zachary Zumsteg
7 papers · 7 as a resident
Neil Desai
6 papers · 3 as a resident

Clinical trials

Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2014–2023
Image-Guided Radiation Therapy for Bladder-Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2010–2026
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
Site PI · Recruiting · Phase 3
M.D. Anderson Cancer Center
2024–2029